Results
The proportions of patients who had a recurrence of atrial fibrillation after a mean follow-up of 16 months were:
- 35% for amiodarone
- 63% for sotalol/propafenone
- p < 0.001
Amiodarone resulted in a higher rate of adverse events necessitating discontinuation of therapy:
- 18% for amiodarone
- 11% for sotalol/propafenone
- p = 0.06
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page